Abstracts and Awards

Vascular Discovery: From Genes to Medicine
Scientific Sessions 2019

Formerly ATVB|PVD Scientific Sessions

May 14–16, 2019
Marriott Copley Square Hotel | Boston, Massachusetts

Sponsored by: Arteriosclerosis, Thrombosis and Vascular Biology Council
Peripheral Vascular Disease Council and Genomics & Precision Medicine Council

2019 Abstract Submission Categories

  • Apolipoproteins, Lipoproteins and Lipid Metabolism
  • Aortic Aneurysm Disease
  • Blood Coagulation and Antithrombotic Therapy
  • Cardiovascular Precision Medicine
  • Genomics, Epigenomics, and Stem Cells in Vascular Disease
  • Immune Mechanisms of Atherosclerosis
  • Immunity and Inflammation in Vascular Biology
  • Inflammation and Hemostasis

Download the complete Rules and Guidelines for Abstract Submission (PDF).

  • Metabolic Disorders and Atherosclerosis
  • Molecular and Cellular Mechanisms of Atherosclerosis
  • Molecular, Developmental, and Cellular Biology of Vessel Wall
  • Peripheral Artery Disease, Carotid Artery Disease and Stroke
  • Platelet Production, Signaling and Function
  • Population Science, Genetics, and Genomics in Vascular Discovery
  • Therapeutic Targets in Atherosclerosis
  • Venous Thromboembolism and Lymphatic Disease

Abstract submission is now closed for 2019.

Awards Submissions

Early Career and Mid-Career Awards
Sponsored by the ATVB, PVD and GPM Councils

Applications for these awards may be made by submitting abstracts for presentation at Vascular Discovery: From Genes to Medicine. 
Submission deadline: January 25, 2019 at 11:59 p.m.

Other Awards

  • Jeffrey M. Hoeg Arteriosclerosis, Thrombosis and Vascular Award for Basic Science and Clinical Research (link opens in new window) : Eligible candidates must have a doctoral degree, and have held a minimum academic rank of assistant professor for no less than 3 years, up to a maximum rank of full professor for no more than 5 years. Award and abstract submission dates are October 30, 2018 through February 1, 2019. This award honors the memory of Jeffrey M. Hoeg, M.D., chief of the Section of Cell Biology within the Molecular Disease Branch of the National Heart, Lung, and Blood Institute, NIH. He was an extraordinary research scientist and physician who, in the prime of his career, was working in the field of lipoprotein metabolism and atherosclerosis. Dr. Hoeg died in July 1998 after a courageous battle with cancer.